Copyright © 2004 The American Society of Human Genetics. All rights reserved.
The American Journal of Human Genetics, Volume 74, Issue 3, 466-471, 1 March 2004
doi:10.1086/382195
Katsuhiko Inagaki1, *, Tamio Suzuki1, *,
,
, Hiroshi Shimizu2, Norihisa Ishii3, Yoshinori Umezawa4, Joji Tada5, Noriaki Kikuchi6, Minoru Takata7, Kenji Takamori8, Mari Kishibe9, Michi Tanaka10, Yoshinori Miyamura1, Shiro Ito1 and Yasushi Tomita1
1 Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan
2 Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
3 Department of Bioregulation, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo
4 Department of Dermatology, Tokai University School of Medicine, Isehara, Japan
5 Department of Dermatology, Okayama Municipal Hospital, Okayama, Japan
6 Department of Plastic Surgery, Nihonkai Hospital, Sakata, Japan
7 Department of Dermatology, Toyama Prefectural Central Hospital, Toyama, Japan
8 Department of Dermatology, Juntendo University Urayasu Hospital, Urayasu, Japan
9 Department of Dermatology, Asahikawa Medical College, Asahikawa, Japan
10 Department of Dermatology, Mito National Hospital, Mito, Japan
Address for correspondence and reprints: Dr. Tamio Suzuki, Nagoya University Graduate School of Medicine, Department of Dermatology, 65 Tsurumai, Showa-ku, Nagoya, JapanAbstract
Oculocutaneous albinism (OCA) is a complex genetic disease with great clinical heterogeneity. Four different types of OCA have been reported to date (OCA1, OCA2, OCA3, and OCA4). MATP was recently reported in a single Turkish OCA patient as the fourth pathological gene, but no other patients with OCA4 have been reported. Here, we report the mutational profile of OCA4, determined by genetic analysis of the MATP gene in a large Japanese population with OCA. Of 75 unrelated patients that were screened, 18 individuals (24%) were identified as having OCA4; they harbored seven novel mutations, including four missense mutations (P58S, D157N, G188V, and V507L) and three frameshift mutations (S90CGGCCA→GC, V144insAAGT, and V469delG), showing that MATP is the most frequent locus for tyrosinase-positive OCA in Japanese patients. We discuss the functional melanogenic activity of each mutant allele, judging from the relationship between the phenotypes and genotypes of the patients. This is the first report on a large group of patients with OCA4.
| Rufous Oculocutaneous Albinism in Southern African Blacks Is Caused by Mutations in the TYRP1 Gene The American Journal of Human Genetics, Volume 61, Issue 5, 1 November 1997, Pages 1095-1101 P. Manga, J.G.R. Kromberg, N.F. Box, R.A. Sturm, T. Jenkins and M. Ramsay Abstract Summary:
Oculocutaneous albinism (OCA) is the most common autosomal recessive disorder among southern African Blacks. There are three forms that account for almost all OCA types in this region. Tyrosinase-positive OCA (OCA2), which is the most common, affects ∼1/3,900 newborns and has a carrier frequency of ∼1/33. It is caused by mutations in the P gene on chromosome 15. Brown OCA (BOCA) and rufous OCA (ROCA) account for the majority of the remaining phenotypes. The prevalence of BOCA is unknown, but for ROCA it is ∼1/8,500. Linkage analysis performed on nine ROCA families showed that ROCA was linked to an intragenic marker at the TYRP1 locus (maximum LOD score = 3.80 at θ=.00). Mutation analysis of 19 unrelated ROCA individuals revealed a nonsense mutation at codon 166 (S166X) in 17 (45%) of 38 ROCA chromosomes, and a second mutation (368delA) was found in an additional 19 (50%) of 38 chromosomes; mutations were not identified in the remaining 2 ROCA chromosomes. In one family, two siblings with a phenotypically unclassified form of albinism were found to be compound heterozygotes for mutations (S166X/368delA) at the TYRP1 locus and were heterozygous for a common 2.7-kb deletion in the P gene. These findings have highlighted the influence of genetic background on phenotype, in which the genotype at one locus can be influenced by the genotype at a second locus, leading to a modified phenotype. ROCA, which in southern African Blacks is caused by mutations in the TYRP1 gene, therefore should be referred to as “OCA3,” since this is the third locus that has been shown to cause an OCA phenotype in humans. Abstract | | |
| MC1R Mutations Modify the Classic Phenotype of Oculocutaneous Albinism Type 2 (OCA2) The American Journal of Human Genetics, Volume 73, Issue 3, 1 September 2003, Pages 638-645 Richard A. King, Rebecca K. Willaert, Ramona M. Schmidt, Jacy Pietsch, Sarah Savage, Marcia J. Brott, James P. Fryer, C. Gail Summers and William S. Oetting Abstract The heterogeneous group of disorders known as oculocutaneous albinism (OCA) shares cutaneous and ocular hypopigmentation associated with common developmental abnormalities of the eye. Mutations of at least 11 loci produce this phenotype. The majority of affected individuals develop some cutaneous melanin; this is predominantly seen as yellow/blond hair, whereas fewer have brown hair. The OCA phenotype is dependent on the constitutional pigmentation background of the family, with more OCA pigmentation found in families with darker constitutional pigmentation, which indicates that other genes may modify the OCA phenotype. Sequence variation in the melanocortin-1 receptor (MC1R) gene is associated with red hair in the normal population, but red hair is unusual in OCA. We identified eight probands with OCA who had red hair at birth. Mutations in the P gene were responsible for classic phenotype of oculocutaneous albinism type 2 (OCA2) in all eight, and mutations in the MC1R gene were responsible for the red (rather than yellow/blond) hair in the six of eight who continued to have red hair after birth. This is the first demonstration of a gene modifying the OCA phenotype in humans. Abstract | | |
| A Germline Mutation in BLOC1S3/Reduced Pigmentation Causes a Novel Variant of Hermansky-Pudlak Syndrome (HPS8) The American Journal of Human Genetics, Volume 78, Issue 1, 1 January 2006, Pages 160-166 Neil V. Morgan, Shanaz Pasha, Colin A. Johnson, John R. Ainsworth, Robin A.J. Eady, Ban Dawood, Carole McKeown, Richard C. Trembath, Jonathan Wilde, Steve P. Watson and Eamonn R. Maher Abstract Hermansky-Pudlak syndrome (HPS) is genetically heterogeneous, and mutations in seven genes have been reported to cause HPS. Autozygosity mapping studies were undertaken in a large consanguineous family with HPS. Affected individuals displayed features of incomplete oculocutaneous albinism and platelet dysfunction. Skin biopsy demonstrated abnormal aggregates of melanosomes within basal epidermal keratinocytes. A homozygous germline frameshift mutation in BLOC1S3 (p.Gln150ArgfsX75) was identified in all affected individuals. BLOC1S3 mutations have not been previously described in patients with HPS, but BLOC1S3 encodes a subunit of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Mutations in other BLOC-1 subunits have been associated with an HPS phenotype in humans and/or mouse, and a nonsense mutation in the murine orthologue of BLOC1S3 causes the reduced pigmentation (rp) model of HPS. Interestingly, eye pigment formation is reported to be normal in rp, but we found visual defects (nystagmus, iris transilluminancy, foveal hypoplasia, reduced visual acuity, and evidence of optic pathway misrouting) in affected individuals. These findings define a novel form of human HPS (HPS8) and extend genotype-phenotype correlations in HPS. Abstract | | |